ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,787 | -27.7% | 66,518 | -4.0% | 0.02% | -25.0% |
Q2 2023 | $2,470 | +35.6% | 69,255 | -3.4% | 0.02% | +25.0% |
Q1 2023 | $1,821 | -39.6% | 71,700 | -3.6% | 0.02% | -40.7% |
Q4 2022 | $3,017 | -99.9% | 74,388 | +1.8% | 0.03% | +17.4% |
Q3 2022 | $2,415,000 | -3.9% | 73,081 | +2.4% | 0.02% | 0.0% |
Q2 2022 | $2,512,000 | -23.1% | 71,357 | +0.5% | 0.02% | -8.0% |
Q1 2022 | $3,266,000 | -66.6% | 71,009 | -51.9% | 0.02% | -30.6% |
Q4 2021 | $9,780,000 | +113.2% | 147,506 | +100.8% | 0.04% | -7.7% |
Q3 2021 | $4,587,000 | -31.8% | 73,469 | -9.5% | 0.04% | -27.8% |
Q2 2021 | $6,722,000 | +555.2% | 81,165 | +424.8% | 0.05% | +42.1% |
Q1 2021 | $1,026,000 | -19.4% | 15,466 | -6.7% | 0.04% | -20.8% |
Q4 2020 | $1,273,000 | +80.1% | 16,585 | +1.0% | 0.05% | +54.8% |
Q3 2020 | $707,000 | -3.5% | 16,425 | -3.2% | 0.03% | -8.8% |
Q2 2020 | $733,000 | +39.9% | 16,965 | -6.9% | 0.03% | +161.5% |
Q1 2020 | $524,000 | -54.0% | 18,218 | +1.5% | 0.01% | -38.1% |
Q4 2019 | $1,138,000 | +132.2% | 17,944 | +3.1% | 0.02% | +110.0% |
Q3 2019 | $490,000 | +4.7% | 17,404 | -1.5% | 0.01% | -9.1% |
Q2 2019 | $468,000 | +89.5% | 17,672 | +31.4% | 0.01% | +83.3% |
Q1 2019 | $247,000 | +55.3% | 13,444 | +5.0% | 0.01% | +20.0% |
Q4 2018 | $159,000 | -12.2% | 12,804 | -3.6% | 0.01% | +25.0% |
Q2 2018 | $181,000 | – | 13,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |